Avammune Therapeutics is a drug discovery company.
Avammune Therapeutics has raised $12.0M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
Avammune Therapeutics's investors include IvyCap Ventures, Shastra VC, Kotak Alternate Asset Managers, 1Crowd, The Chennai Angels.
Avammune Therapeutics is headquartered in Philadelphia, United States.
Avammune Therapeutics is a drug discovery company.
Avammune Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avammune Therapeutics — Funding & Investors." VCBacked, May 7, 2025, https://www.vcbacked.co/company/avammune-therapeutics. Accessed October 23, 2026.
VCBacked. (2025). Avammune Therapeutics — Funding & Investors. Retrieved October 23, 2026, from https://www.vcbacked.co/company/avammune-therapeutics
{{cite web |title=Avammune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/avammune-therapeutics |website=VCBacked |access-date=October 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated